diagnostics

Biotech By Kate Sheridan

Liquid biopsy startup Grail, in filing for IPO, lays out investments and plans for growth

Health By Kate Sheridan

U.S. needs 193 million Covid-19 tests per month to reopen schools and keep up with pandemic, new report says

Biotech By Elizabeth Cooney

Foundation Medicine wins FDA approval for liquid biopsy able to detect mutations in multiple cancers 

First Opinion By Jeffrey L. Schnipper and Paul E. Sax

Even Covid-19 tests that aren’t perfect can help control the pandemic

Health By Kate Sheridan

Ginkgo Bioworks, Mammoth Biosciences among winners of NIH’s ‘Shark Tank’ for Covid-19 tests 

Pharmalot By Ed Silverman

Cepheid is accused of overcharging and undersupplying its Covid-19 test to poor countries

In the Lab By Elizabeth Cooney

A test you can breathe in: Scientists are developing synthetic biosensors to monitor lung disease

Politics By Matthew Herper

U.S. must spend $75 billion to fix flawed Covid-19 testing, report says

In the Lab By Juliet Isselbacher

Scientists create a speedy finger-prick test to scan for radiation exposure in mice

First Opinion By Prabhavathi Fernandes and Steve Brozak

Lack of rapid diagnostic tools contributes to Covid-19 deaths

Health By Erin Brodwin

Experts decry FDA’s halting of a high-profile Covid-19 study over approvals

Health Tech By Rebecca Robbins

AI systems are worse at diagnosing disease when training data is skewed by sex

Health By Matthew Herper

FDA says Abbott’s 5-minute Covid-19 test may miss infected patients

Health By STAT staff

Watch: Testing failures have plagued the U.S. response to Covid-19. How did we get here?

Health By Elizabeth Cooney

7 questions about Covid-19 testing and what it means for reopening the country

Politics By Lev Facher

NIH announces $1.5 billion, ‘Shark Tank’-like initiative to accelerate Covid-19 testing

Biotech By Kate Sheridan

For the first time, a blood test helped doctors find and treat multiple types of cancer in seemingly healthy people

First Opinion By Elliott J. Millenson

Home testing for Covid-19 will provide the combination to unlock the U.S.

Health By Erin Brodwin

FDA greenlights first Covid-19 test with at-home sample collection

Health By Erin Brodwin

Scientists tap CRISPR’s search-and-detect skills to create a rapid Covid-19 test

First Opinion By Brian H. Shirts

We’ll see more shortages of diagnostic tests if the FDA has its way

Health Tech By Erin Brodwin

Startups spar with FDA over what constitutes a home coronavirus test

Health Tech By Shafaq Zia

‘Smart toilet’ could monitor for signs of illness in urine and stool, study finds

First Opinion By Arjun K. Manrai and Kenneth D. Mandl

Covid-19 testing: overcoming challenges in the next phase of the epidemic

Health By Matthew Herper

Test makers are moving fast, but the coronavirus may be moving faster